Given the functional correlation between TMC proteins and CIBs in inner ear hair cells, targeted Cib2 gene therapy warrants systematic investigation, with Tmc1’s therapeutic success supporting its potential for treating CIB2-related hearing loss. The gene discussed is CIB2; the disease is hearing loss disorder.